D-1863-2019 Class II Terminated

Recalled by West-Ward Columbus Inc — Columbus, OH

FDA drug recall D-1863-2019 was initiated by West-Ward Columbus Inc on Sep 9, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specificattion The recall status is terminated (terminated Jun 15, 2022). Affected quantity: 32,347 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 25, 2019
Initiation Date
Sep 9, 2019
Termination Date
Jun 15, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
32,347 bottles

Product description

Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-Ward Pharmaceuticals,Eatontown, NJ. NDC:0054-0199-59

Reason for recall

Failed Impurities/Degradation Specificattion

Distribution pattern

Nationwide USA and Puerto Rico

Code information

Lot, expiry: Lots AA3957A, AA3958A, exp May 2020; Lot AA5164A, exp Sep 2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1863-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1863-2019. Report a data issue: hello@regdatalab.com.